SymBio Pharmaceuticals
SymBio Pharmaceuticals engages in in-license, development, and commercialization of drugs for the therapeutic areas of cancer.
Business Model:
Revenue: $30.6M
Employees: 51-200
Industries / Tags:
Detailed SymBio Pharmaceuticals Information
Geographic Data
Address: San-Ei Bldg.
City: Minato-ku
State: tōkyō prefecture
Zip: 1050004
Country: JP
Financial Info
Stage:
post ipo debt
Raised Last:
$27M
Raised Total:$24M
Social
Metrics
2,095,432Website Global Rank
9,550Website Monthly Traffic
Twitter Followers
Description
SymBio Pharmaceuticals engages in in-license, development, and commercialization of drugs for the therapeutic areas of cancer.
Contact Phone:
Contact Email:
SymBio Pharmaceuticals went public on 7/16/2013 on the Taiwan Stock Exchange
Listed Exchange:
Taiwan Stock Exchange
IPO Date:
7/16/2013
Ticker Symbol:
4582
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
